Lanplus 30 mg (Capsule (Enteric Coated))

Unit Price: ৳ 10.00 (5 x 6: ৳ 300.00)
Strip Price: ৳ 60.00

Medicine Details

Category Details
Generic Dexlansoprazole
Company Radiant pharmaceuticals ltd
Also available as

Indications

  • Healing of Erosive Esophagitis
  • Maintenance of Healed Erosive Esophagitis
  • Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Pharmacology

  • Proton Pump Inhibitor (PPI)
  • Gastric acid secretion suppression
  • Specific inhibition of (H⁺/K⁺)-ATPase
  • Dual Delayed Release (DDR) formulation
  • Plasma concentration-time profile with two distinct peaks

Dosage

  • 30 mg Once daily for Maintenance of Healed erosive esophagitis and relief of heartburn
  • 30 mg Once daily for Symptomatic Non-Erosive GERD
  • 60 mg Once daily for Healing of erosive esophagitis
  • 30 mg tablet once daily for 6 months in adults and 16 weeks in patients 12 to 17 years of age
  • Granules should not be chewed

Administration

  • Can be taken without regard to food
  • Swallowed whole
  • Alternatively administered by sprinkling intact granules on one tablespoon and swallowing immediately
  • Missed capsule should be taken as soon as possible or only the prescribed dose taken at the appointed time

Interaction

  • With medicine: Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate. With food & others: No data available

Contraindications

  • Hypersensitivity to any component of the formulation

Side Effects

  • Diarrhea
  • Abdominal pain
  • Nausea
  • Vomiting
  • Flatulence

Pregnancy & Lactation

  • Pregnancy Category B
  • No adequate and well-controlled studies with Dexlansoprazole in pregnant women
  • No adequate and well-controlled studies with Dexlansoprazole in Lactating mother

Precautions & Warnings

  • Gastric Malignancy
  • Clostridium difficile Associated Diarrhea
  • Bone fracture
  • Hypomagnesemia
  • Concomitant use with Methotrexate

Use in Special Populations

  • Safety and effectiveness not established in patients below 12 years age
  • No dose adjustment for elderly patients
  • No dose adjustment for renal impairment
  • No dose adjustment for patients with mild hepatic impairment
  • Consider maximum daily dose of 30 mg for patients with moderate hepatic impairment

Overdose Effects

  • No reports of significant overdose
  • Multiple doses of 120 mg and a single dose of 300 mg did not result in severe adverse events

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Store below 30°C temperature
  • Store in a dry place protected from light
  • Keep all medicines out of reach of children

Related Brands